Anti-TAAR3 monoclonal antibody

Pre-made anti-TAAR3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TAAR3/TAAR3P products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T82922-Ab-1/ GM-Tg-hg-T82922-Ab-2Anti-Human TAAR3/TAAR3P monoclonal antibodyHuman
GM-Tg-rg-T82922-Ab-1/ GM-Tg-rg-T82922-Ab-2Anti-Rat TAAR3/TAAR3P monoclonal antibodyRat
GM-Tg-mg-T82922-Ab-1/ GM-Tg-mg-T82922-Ab-2Anti-Mouse TAAR3/TAAR3P monoclonal antibodyMouse
GM-Tg-cynog-T82922-Ab-1/ GM-Tg-cynog-T82922-Ab-2Anti-Cynomolgus/ Rhesus macaque TAAR3/TAAR3P monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T82922-Ab-1/ GM-Tg-felg-T82922-Ab-2Anti-Feline TAAR3/TAAR3P monoclonal antibodyFeline
GM-Tg-cang-T82922-Ab-1/ GM-Tg-cang-T82922-Ab-2Anti-Canine TAAR3/TAAR3P monoclonal antibodyCanine
GM-Tg-bovg-T82922-Ab-1/ GM-Tg-bovg-T82922-Ab-2Anti-Bovine TAAR3/TAAR3P monoclonal antibodyBovine
GM-Tg-equg-T82922-Ab-1/ GM-Tg-equg-T82922-Ab-2Anti-Equine TAAR3/TAAR3P monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T82922-Ab-1/ GM-Tg-hg-T82922-Ab-2; GM-Tg-rg-T82922-Ab-1/ GM-Tg-rg-T82922-Ab-2;
GM-Tg-mg-T82922-Ab-1/ GM-Tg-mg-T82922-Ab-2; GM-Tg-cynog-T82922-Ab-1/ GM-Tg-cynog-T82922-Ab-2;
GM-Tg-felg-T82922-Ab-1/ GM-Tg-felg-T82922-Ab-2; GM-Tg-cang-T82922-Ab-1/ GM-Tg-cang-T82922-Ab-2;
GM-Tg-bovg-T82922-Ab-1/ GM-Tg-bovg-T82922-Ab-2; GM-Tg-equg-T82922-Ab-1/ GM-Tg-equg-T82922-Ab-2
Products NameAnti-TAAR3/TAAR3P monoclonal antibody
Formatmab
Target NameTAAR3
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TAAR3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T82922-Ag-1Recombinant multi-species TAAR3/ TAAR3P/ GPR57 protein


    Target information

    Target IDGM-T82922
    Target NameTAAR3
    Gene ID9288
    Gene Symbol and SynonymsGPR57,GPR58,TAAR2,TAAR3,TAAR3P
    Uniprot AccessionQ9P1P4
    Uniprot Entry NameTAAR3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000179073
    Target ClassificationGPCR

    The target: TAAR3, gene name: TAAR3P, also named as GPR57, GPR58, TAAR2, TAAR3. Predicted to enable trace-amine receptor activity. Predicted to be involved in sensory perception of chemical stimulus. Predicted to be located in plasma membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.